Nobel Award Recognizes Pioneering Body's Defenses Discoveries
The prestigious award in medical science was granted for revolutionary findings that illuminate how the body's defense network targets harmful infections while protecting the body's own cells.
A trio of renowned researchers—from Japan Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—share this accolade.
The research identified unique "sentinels" within the immune system that eliminate rogue defense cells capable of harming the body.
The findings are now paving the way for new treatments for autoimmune diseases and malignancies.
These winners will share a monetary award worth 11 million Swedish kronor.
Decisive Discoveries
"The work has been essential for comprehending how the immune system operates and why we do not all suffer from severe self-attack conditions," commented the head of the award panel.
This trio's studies address a fundamental question: How does the immune system defend us from countless invaders while leaving our own tissues unharmed?
Our body's protection system employs immune cells that scan for signs of infection, including pathogens and bacteria it has never encountered.
These defenders utilize sensors—known as receptors—that are produced randomly in a vast number of combinations.
That provides the defense network the capacity to fight a wide array of threats, but the unpredictability of the mechanism unavoidably creates immune cells that can target the host.
Protectors of the Immune System
Researchers earlier knew that some of these harmful defense cells were destroyed in the thymus—the site where white blood cells develop.
The latest Nobel Prize recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the system to disarm other immune cells that attack the body's own tissues.
We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.
The prize committee stated, "The findings have established a novel area of research and spurred the creation of new therapies, for instance for cancer and autoimmune diseases."
In cancer, T-regs block the system from fighting the growth, so research are focused on lowering their numbers.
In autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not under attack. A comparable method could also be effective in reducing the chances of organ transplant failure.
Pioneering Experiments
Professor Sakaguchi, of a Japanese institution, performed tests on mice that had their thymus removed, leading to autoimmune disease.
He demonstrated that introducing immune cells from healthy mice could prevent the illness—suggesting there was a system for preventing defenders from attacking the host.
Mary Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an genetic autoimmune disease in rodents and people that resulted in the identification of a genetic factor vital for the way T-regs operate.
"The pioneering research has revealed how the body's defenses is controlled by T-reg cells, stopping it from accidentally targeting the healthy cells," commented a leading biological science specialist.
"The work is a remarkable illustration of how basic physiological research can have far-reaching consequences for public health."
